Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Steroid sulfatase (STS) is an enzyme (EC 3.1.6.2) that catalyzes the hydrolysis of steroid sulfates into their unconjugated forms, regulating the formation and bioavailability of biologically active steroids. It is a therapeutic target in hormone-dependent cancers and its deficiency leads to X-linked ichthyosis. Inhibitors of STS, such as Irosustat, are being developed to reduce local estrogen synthesis in tumors.
Inhibition of steroid sulfatase, reducing local estrogen synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Steroid Sulfatase (STS).